CD4 and COVID-19: However, in COVID-19 patients with concomitant aTB, SARS-CoV-2–specific CD4+ T cells displayed lower polyfunctional capacity, characterized by significant reduction of the cells with 3 functions, compared with HIV–/aTB– patients (Figure 6G).